試す 金 - 無料
ADVANCEMENTS IN NEUROFEEDBACK THERAPY: IMPLICATIONS FOR TREATING NEURODIVERGENT STUDENTS IN ACADEMIC ENVIRONMENTS
Healthcare Radius
|February 2025
With ongoing research and innovation, the future of neurofeedback therapy holds significant promise for transforming the educational experiences of neurodivergent youngsters.

For children with neurodivergent disorders, neurofeedback therapy, a type of biofeedback, is a noninvasive approach that may improve their cognitive, emotional, and behavioral skills. These students often face significant obstacles in the classroom that they must overcome, and students who struggle with focus, emotional control, sensory processing, and social interaction may find it more difficult to succeed academically as a result of these issues. Neurofeedback may be a viable solution that may help students regulate the activity in their brains and directly address the trouble they are experiencing.
THE PROCESS OF NEUROFEEDBACK THERAPY: HOW IT WORKS
Neurofeedback therapy begins with an assessment of the client’s brainwave activity. In other words, it is known as brain mapping which is done by attaching one or more sensors to a person’s scalp and/ or ears lobe(s). These are linked to an EEG machine, which displays the person’s brain waves on a computer in the form of lines, graphs or even a video game. For instance, what we see in the game may be a car moving or a ball coming up and going down. With the brain, the person is requested to make the line, graph or object to move. If the brain activity is optimal/desirable, the video game speeds up, or the ball goes up. Undesirable/adverse brain activity makes the ball slow down, prompting the student to adjust their brainwave patterns. Over time the brain develops new patterns thereby making the brain functions effective and reducing problematic symptoms. The Neurofeedback sessions may take 2060 minutes per training session and would largely involve alternating between training and break sessions. Depending on the student’s needs, the duration of the therapy may vary. Some students shows significant improvement in 10 sessions while others may require more.

このストーリーは、Healthcare Radius の February 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、9,500 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Healthcare Radius からのその他のストーリー

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size